1.
2. First Case of 2019 Novel Coronavirus in the United States
3. An Open Letter from Daniel O'Day Chairman & CEO Gilead Sciences Daniel O'Day—June 22 2020.
4. US Food and Drug Administration. Remdesivir EUA letter of authorization 2020. Available:https://www.fda.gov/media/137564/download [Accessed 1 May2020].
5. An Open Letter from Daniel O'Day Chairman & CEO Gilead Sciences on June 29 2020:https://www.gilead.com/stories/articles/an-open-letter-from-daniel-oday-june-29.